Page 316 - IJB-9-3
P. 316

International Journal of Bioprinting                            Bioprinted stem cell niche regenerates muscles



            3D construct can be released slowly with time into adjacent   References
            tissues, which could be beneficial for stem cell survival and
            persistence surrounding the implanted construct.   1.   Sacco A, Mourkioti F, Tran R, et al., 2010, Short telomeres
                                                                  and stem cell exhaustion model Duchenne muscular
            5. Conclusion                                         dystrophy in mdx/mTR mice. Cell, 143(7):1059–1071.

            Our current result indicates that the reactivation of Notch   https://doi.org/10.1016/j.cell.2010.11.039
            signaling in dystrophic muscle is effective in promoting   2.   Jang YC, Sinha M, Cerletti M, et al., 2011, Skeletal muscle
            self-renewal of muscle stem cells, and demonstrates that   stem cells: Effects of aging and metabolism on muscle
            bioprinting of Notch activator can be applied to serve as   regenerative function. Cold Spring Harb Symp Quant Biol,
            stem cell niche and improve the efficacy of muscle stem   76:101–111.
            cell transplantation in diseased muscle. We believe that   https://doi.org/10.1101/sqb.2011.76.010652
            the same technology could possibly be adapted for the
            treatment of a wide variety of traumatic and atraumatic   3.   Usas A, Maciulaitis J, Maciulaitis R,  et  al., 2011, Skeletal
            muscle conditions in the future.                      muscle-derived stem cells: Implications for cell-mediated
                                                                  therapies. Medicina (Kaunas), 47(9):469–479.
            Acknowledgments                                    4.   Ikezawa M, Cao B, Qu Z, et al., 2003, Dystrophin delivery in
                                                                  dystrophin-deficient DMDmdx skeletal muscle by isogenic
            We greatly appreciate the fundings or supports from   muscle-derived stem cell transplantation. Hum Gene Ther,
            Shandong First medical University and Shandong        14(16):1535–1546.
            Academy of Medical Science, and Steadman Philippon
            Research Institute (SPRI).                            https://doi.org/10.1089/104303403322495043
                                                               5.   Winkler T, von Roth P, Matziolis G, et al., 2009, Dose-response
            Conflict of interest                                  relationship of mesenchymal stem cell transplantation and
            The authors declare no conflict of interest.          functional regeneration after severe skeletal muscle injury in
                                                                  rats. Tissue Eng Part A, 15(3):487–492.
            Author contributions                                  https://doi.org/10.1089/ten.tea.2007.0426
            Conceptualization:  Lee Weiss, Phil Campbell, Johnny   6.   Tremblay JP, Malouin F, Roy R,  et al., 1993, Results of a
               Huard, Xiaodong Mu                                 triple blind clinical study of myoblast transplantations
            Formal analysis: Zewei Sun, Xianlin Yue, Lei Liu, Ying Li  without immunosuppressive treatment in young boys
            Investigation: Zewei Sun, Xianlin Yue, Lei Liu, Ying Li,    with Duchenne muscular dystrophy. Cell Transplant, 2(2):
               Jie Cui                                            99–112.
            Methodology: Zewei Sun, Xianlin Yue, Lee Weiss, Phil   7.   Drowley L, Okada M, Beckman S,  et al., 2010, Cellular
               Campbell, Johnny Huard, Yanling Mu, Xiaodong Mu    antioxidant levels influence muscle stem cell therapy. Mol
            Visualization:  Zewei  Sun,  Xianlin  Yue,  Johnny  Huard,   Ther, 18(10):1865–1873.
               Xiaodong Mu                                        https://doi.org/10.1038/mt.2010.160
            Writing – original draft: Zewei Sun, Xianlin Yue, Johnny
               Huard, Xiaodong Mu                              8.   Maclean S, Khan WS, Malik AA, et al., 2012, The potential
            Writing – review & editing: Zewei Sun, Xianlin Yue, Johnny   of stem cells in the treatment of skeletal muscle injury and
                                                                  disease. Stem Cells Int, 2012:282348.
               Huard , Yanling Mu, Xiaodong Mu
                                                                  https://doi.org/10.1155/2012/282348
            Ethics approval and consent to participate         9.   Gussoni E, Blau HM, Kunkel LM, 1997, The fate of

            All procedures were approved by the Institutional Animal   individual myoblasts after transplantation into muscles of
            Care and Use Committee (IACUC) at the University of   DMD patients. Nat Med, 3(9):970–977.
            Pittsburgh (IACUC-1109718).                        10.  Karpati G, Holland P, Worton RG, 1992, Myoblast transfer
                                                                  in DMD: Problems in the interpretation of efficiency. Muscle
            Consent for publication                               Nerve, 15(10):1209–1210.

            Not applicable.                                       https://doi.org/10.1002/mus.880151016
                                                               11.  Mayeuf A, Relaix F, 2011, Notch pathway: From
            Availability of data                                  development to regeneration of skeletal muscle.  Med Sci
            The data that support the findings of this study are available   (Paris), 27(5):521–526.
            from the corresponding author upon reasonable request.  https://doi.org/10.1051/medsci/2011275018

            Volume 9 Issue 3 (2023)                        308                         https://doi.org/10.18063/ijb.711
   311   312   313   314   315   316   317   318   319   320   321